Supplementary Table S2 from PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial
Juan Pablo Alderuccio,Isildinha M. Reis,Mehdi Hamadani,Muthiah Nachiappan,Salman Leslom,Brad S. Kahl,Weiyun Z. Ai,John Radford,Melhem Solh,Kirit M. Ardeshna,Brian T. Hess,Matthew A. Lunning,Pier Luigi Zinzani,Anastasios Stathis,Carmelo Carlo-Stella,Izidore S. Lossos,Paolo F. Caimi,Sunwoo Han,Fei Yang,Russ A. Kuker,Craig H. Moskowitz
